Fulltext

The Second Asia-Oceania Human Proteome Organization (AOHUPO) Online Education Series on the Renaissance of Clinical Proteomics: Biomarkers, Imaging and Therapeutics

Low TY 1 , Chen YJ 2 , Ishihama Y 3 , Chung MCM 4 , Cordwell S 5 , Poon TCW 6 Show all authors , Kwon HJ 7

Affiliations 

  • 1 UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
  • 2 Institute of Chemistry, Academia Sinica, Taipei, Taiwan
  • 3 Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
  • 4 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
  • 5 School of Life and Environmental Sciences and Sydney Mass Spectrometry, The University of Sydney, Sydney, Australia
  • 6 Pilot Laboratory, Proteomics Core, Institute of Translational Medicine, Centre for Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau SAR, China
  • 7 Chemical Genomics Leader Research Initiative, Department of Biotechnology, Yonsei University, Seoul, South Korea. Electronic address: kwonhj@yonsei.ac.kr
Mol Cell Proteomics, 2022 Dec;21(12):100436.
PMID: 36309314 DOI: 10.1016/j.mcpro.2022.100436

Abstract

In 2021, the Asia-Oceania Human Proteome Organization (AOHUPO) initiated a new endeavor named the AOHUPO Online Education Series with the aim to promote scientific education and collaboration, exchange of ideas and culture among the young scientists in the AO region. Following the warm participation, the AOHUPO organized the second series in 2022, with the theme "The Renaissance of Clinical Proteomics: Biomarkers, Imaging and Therapeutics". This time, the second AOHUPO Online Education Series was hosted by the UKM Medical Molecular Biology Institute (UMBI) affiliated to the National University of Malaysia (UKM) in Kuala Lumpur, Malaysia on three consecutive Fridays (11th, 18th and 25th of March). More than 300 participants coming from 29 countries/regions registered for this 3-days event. This event provided an amalgamation of six prominent speakers and all participants whose interests lay mainly in applying MS-based and non-MS-based proteomics for clinical investigation.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications